NIDA awards $1.4M grant to aid development of formal addiction medicine training programs

Boston Medical Center (BMC) physician Jeffrey Samet, MD, chief, section of general internal medicine, in collaboration with Co-Principal Investigator, Patrick O'Connor, MD, chief section of general internal medicine at Yale School of Medicine, were awarded a five-year, $1.4 million grant from the National Institute On Drug Abuse (NIDA) to aid the development of formal addiction medicine training programs.

With the number of addiction medicine residency programs steadily increasing, the proposed Research in Addiction Medicine Scholars (RAMS) Program will aim to create an infrastructure to facilitate these programs' development of strong research components and encourage physician careers in this area.

"The RAMS Program is significant because it will expand the nation's research capacity among trainees in the new medical specialty of addiction medicine," said Samet. "This will ultimately improve patient care and reduce the medical, social and financial burden of drug abuse and addiction."

The program will be eligible to addiction medicine and addiction psychiatry trainees who are based in medical schools and teaching hospitals. The RAMS Program will collaborate with the American Board of Addiction Medicine Foundation whose goal is to have the Accreditation Council for Graduate Medical Education accredit the addiction medicine training programs and have the American Board of Medical Specialties recognize addiction medicine. In addition to facilitating addiction medicine research, the program's goal is to integrate mentor training as well as develop a RAMS alumni network to provide career guidance and perspective on a potential future research career advancing addiction research.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options